Observe Medical Asa · OSL:OBSRV
Observe Medical Asa — H1 2024 Earnings Presentation
16 slides from Observe Medical Asa's earnings presentation, Aug 26, 2024
Slide 1: Observe Medical First half year 2024
oKeorserve medical Observe Medical First half year 2024 26 August 2024
Slide 2: Copyright and disclaimer
Copyright and disclaimer Copyright Copyright of all published material including photographs, drawings and images in this document remains vested in Observe Medical and third-party contributors as appropriate. Accordingly, neither the whole nor any part of this document shall be reproduced in any fo
Slide 3: Today's presenters and agenda
Today’s presenters Agenda 1. H1 2024 highlights and progress 2. Key financials 3. Outlook Johan M. Fagerli 4. Q&A Jørgen Mann CEO CFO 20+ years experience from 20 years-experience from the Medtech industry. various roles within Previous experience from financial management, senior roles in market bu
Slide 4: Observe Medical Nordic medtech company with global reach
Observe Medical Nordic medtech company with global reach Commercializing innovative medtech products on a global market. Extensive international distributor and partner network. Solid platform for further organic growth and through targeted M&A. Strong medtech platform Urine Measurement Pocketable M
Slide 5: Highlights H1 2024
Highlights H1 2024 Reclaiming market position Post market surveillance - Biim – Strategic Continued deliveries of UnoMeter 500 and UnoMeterTM 500 partnership UnoMeter Abdo-Pressure to distribution network in UnoMeterTM 500 was upgraded to Contract with Fresenius Europe and Asia with focus on expandi
Slide 6: Product launch planning 2024-2025 - global leader in Urine Measurement
BUSINESS UPDATE – URINE MEASUREMENT Product launch planning 2024-2025 - taking the position as global leader in Urine Measurement Upsell Sippi and Safeti Max to existing Recapture the market through UnoMeter 500 clients at higher price points and better margins UnoMeter 500 Abdo-Pressure UnoMeter Sa
Slide 7: Biim Strategic partnership journey
BUSINESS UPDATE - ULTRASOUND Biim Strategic partnership journey Project status ➢ Fresenius Medical Care is the world’s largest provider ✓ After completion of the Rights issue in December of dialysis, dialysis product and other services 2023, a new strategic direction was defined which led to the sea
Slide 8: Key financials
oKeorserve medical Key financials
Slide 9: Income statement Observe Medical Group
Income statement Observe Medical Group H1 2024 Amounts in NOK thousand (excl. earnings per share) H1 2024 H1 2023 FY 2023 FY 2022 OPERATING REVENUES GROSS PROFIT Operating revenues 13 056 11 819 27 942 19 521 Gros s res ul t 4 990 4 280 9 287 5 177 13.1 MNOK 5.0 MNOK Opera ting expens es 17 599 23 7
Slide 10: Revenue
Revenue growth H1 YoY driven by UnoMeter portfolio (+5.6m/+378%) partly offset by lower sales in the Nordic distribution business 13.056 Comments 11.836 +1.220 1.490 • Revenues of NOK 13.1 million in H1 (+10% YoY). Revenue 7.048 • Significant revenue growth in the urine measurement segment, driven b
Slide 11: EBITDA
EBITDA H1 YOY growth of +10.2m primarily driven by lower Opex (+9.5m) and increased gross profit (+0.7m) +10 158 Comments • The increased gross profit is primarily driven by UnoMeter +9.5m portfolio sales with higher margin. This is partly offset by lower sales from the Nordic portfolio due to the b
Slide 12: Consolidated Cash Flow H1 2024
Consolidated Cash Flow H1 2024 Amounts in NOK thousand 13,676 • Cash flow used in operating activities is mainly the result before tax, deducted for items without cash effect and change in working capital • Positive cash flow from investing activities 10,000 is driven by sale of a company car • Cash
Slide 13: Outlook
oKeorserve medical Outlook
Slide 14: 2024 H2 Deliverables
OUTLOOK 2024 H2 Deliverables • Start deliveries of UnoMeterTM Safeti Plus and continue the increase in market share • Continue development of the distribution network to enable geographical coverage of 85-90% of the historic UnoMeter sales • Continue exploring opportunities for distribution products
Slide 15: Ramp-up from a diversified revenue stream
OUTLOOK Ramp-up from a diversified revenue stream Strong revenue outlook in the medium term ✓ Diversified revenue stream going forward from UnoMeter product family, Sippi® and distribution business ambition ~400-450m ✓ Gross margin currently under pressure on commoditized products, differentiated pr
Slide 16: oKeorserve
oKeorserve medical